日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features

整合多组学分析表明,浸润性肝细胞癌是一种具有独特分子特征的免疫治疗耐药亚型。

Lee, Won Suk; Woo, Seonjeong; Lee, Sung Hwan; Jo, Gae Hoon; Kim, Ilhwan; Kim, Hyeyeong; An, Chansik; Jung, Sanghoon; Kim, Gwangil; Kang, Haeyoun; Kang, Beodeul; Kim, Jung Sun; Lim, Ho Yeong; Kang, Incheon; Yang, Hannah; Kong, So Jung; Son, Dahyeon; Shin, Dong Jun; Kwon, Woo Young; Lee, Da-Yeon; Lee, Ju-Seog; Park, Junho; Kim, Youngsoo; Hwang, Sohyun; Kim, Chan; Chon, Hong Jae

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

晚期肝细胞癌患者在接受阿特珠单抗联合贝伐珠单抗治疗后,再接受纳武利尤单抗联合伊匹木单抗治疗的疗效:一项国际多中心研究

Kim, Jung Sun; Wong, Jeffrey; Chen, San-Chi; Tai, David; Yang, Hannah; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; An, Chansik; Jang, Su Jin; Kudo, Masatoshi; Lim, Ho Yeong; Kim, Chan; Yau, Thomas; Chon, Hong Jae

Sex-Based Differences in Management and Outcomes of Patients Admitted or Transferred to Advanced Therapy Centers for Heart Failure

因心力衰竭入院或转入高级治疗中心的患者在管理和预后方面存在的性别差异

Kim, Ilya; Akinleye, Oluwatoba; Kanduri, Jaya; Subramanyam, Pritha; Krishnan, Udhay; Yeo, Ilhwan; Cheung, Jim; Kim, Luke; Lu, Daniel Yang

Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: a randomized, open-label, multicenter, phase 2 trial

在接受改良FOLFIRINOX方案治疗的不可切除胰腺癌患者中,聚乙二醇化粒细胞集落刺激因子一级预防与不进行预防的比较:一项随机、开放标签、多中心II期试验

Lee, Choong-Kun; Kim, Ilhwan; Seo, Dong Hyun; Park, Sejung; Kim, Minjae; Lee, Sang Hun; Lee, Yong June; Kim, Jung Ho; Kim, Chang Gon; Choi, Hye Jin

Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial

吉西他滨联合顺铂加聚合物胶束紫杉醇治疗晚期胆道癌的生存率:一项随机临床试验

Jeong, Hyehyun; Yoo, Changhoon; Kim, Ilhwan; Kang, Jung Hun; Jeong, Jae Ho; Park, Kwonoh; Oh, Sang-Bo; Park, Inkeun; Sym, Sun Jin; Cheon, Jaekyung; Ryu, Hyewon; Hwang, Jun Eul; Lee, Ji Sung; Ryoo, Baek-Yeol; Kim, Kyu-Pyo

Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-Line Platinum-Based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)

培美曲塞维持治疗与观察治疗在完成一线铂类化疗且未出现疾病进展的晚期尿路上皮癌患者中的疗效比较(PREMIER,KCSG GU16-05)

Park, Inkeun; Yoon, Shinkyo; Kim, Ilhwan; Park, Kwonoh; Lee, Suee; Keam, Bhumsuk; Park, Joo-Hwan; Kim, Jin Young; Choi, Yoon Ji; Sohn, Byeong Seok; Lee, Jae Lyun

Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials

晚期胆道癌二线氟尿嘧啶类化疗:基于随机试验个体患者数据的荟萃分析

Hyung, Jaewon; Kang, Minsu; Kim, Ilhwan; Kim, Kyu-Pyo; Ryoo, Baek-Yeol; Cheon, Jaekyung; Ryu, Hyewon; Lee, Ji Sung; Kim, Ji-Won; Choi, In Sil; Park, Jin Hyun; Abou-Alfa, Ghassan K; Kim, Jin Won; Yoo, Changhoon

A mixed media approach using locally available neutralizing materials for the passive treatment of acid mine drainage

采用混合介质法,利用当地可获得的化学中和材料对酸性矿山排水进行被动处理

Pocaan, Joshua; Turingan, Casey Oliver A; Tabelin, Carlito Baltazar; Zoleta, Joshua B; Arima, Takahiko; Park, Ilhwan; Ito, Mayumi; Orbecido, Aileen H

Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study

晚期肝细胞癌患者接受纳武利尤单抗联合伊匹木单抗治疗后器官特异性反应:一项多中心回顾性研究

Kim, Jung Sun; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; Lee, Won Suk; Hong, Jung Yong; Lim, Ho Yeong; Kim, Han Sang; Kim, Chang Gon; Jung, Sanghoon; An, Chansik; Kim, Chan; Chon, Hong Jae

Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial

血清25-羟基维生素D水平与晚期胆道癌患者生存结局的关系:来自NIFTY试验的结果

Lee, So Heun; Cheon, Jaekyung; Kim, Ilhwan; Kim, Kyu-Pyo; Ryoo, Baek-Yeol; Jeong, Jae Ho; Kang, Myoung Joo; Kang, Byung Woog; Ryu, Hyewon; Lee, Ji Sung; Yoo, Changhoon